Athro XL
Natural health product licensed in Canada
- Licence holder
- JRC Pharmaceuticals
- NPN or DIN-HM
- 80073894
- Status
- Active licence
- Licence date
- 18 November 2016
- Revision date
- 8 May 2017
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : l-Menthol | 1.25 % |
Non-medicinal ingredients
Palmitostéarate de glycéryle, dl-alpha tocophérol, EDTA de sodium, Poly(propylène glycol), Stéarates de poly(oxyéthylène), Huile de sésame, Extrait de racine de Ligusticum Chuanxiong, Diazolidinyl urée, Huile essentielle de Boswellia Carterii, Sodium Citrate Dihydrate, Eau purifiée, Butylcarbamate d'iodopropynyle, Huile essentielle de myrrhe
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 12 years | Not specified | Not specified |
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms persist and/or worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner.
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80073894
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging